J Korean Med Sci.  2007 Jun;22(3):420-424. 10.3346/jkms.2007.22.3.420.

Long-term Follow-up of Laparoscopic Splenectomy in Patients with Immune Thrombocytopenic Purpura

Affiliations
  • 1Department of Surgery, Yonsei University, College of Medicine, 250 Seongsanno, Seodaemun-gu, Seoul, Korea. wjlee@yumc.younsei.ac.kr
  • 2Department of Hematology, Yonsei University, College of Medicine, Seoul, Korea.
  • 3Department of Hematology, Kwandong University, College of Medicine, Goyang, Korea.

Abstract

Laparoscopic splenectomy (LS) has been reserved for intractable and relapsing immune thrombocytopenic purpura (ITP) despite medical treatment. With further experiences of LS in ITP, we investigated long term outcomes of LS, especially newly developed morbidities, and tried to find predictive factors for favorable outcomes. From August 1994 to December 2004, fifty-nine patients whose follow-up period was more than 12 months after LS were investigated. After a long-term follow-up (median 54 months, range 12.5-129 months), a complete response (CR) was found in 28 patients (47.5%), partial response in 24 (40.7%), and no response in 7 (11.9%). The relapse rate during follow-up periods was 15.2%. The rapid response group (p=0.017), in which the platelet count increased more than twice of the preoperative platelet count within 7 days after LS, relapsing after medical treatment (p=0.02), and the satisfactory group as the initial result of LS (p=0.001) were significant for predicting CR in univariate analysis, but only the initial satisfactory group was an independent predictive factor for CR in multivariate analysis (p=0.036, relative risk=6419; 95% CI, 1.171-35.190). Infections were the most frequent morbidities during the follow-up period, which were treated well without mortality. LS is a safe and effective treatment modality for ITP. Active referral to surgery might be required, considering complications and treatment results related to long-term use of steroid-based medications.

Keyword

Laparoscopic Splenectomy (LS); Immune Thrombocytopenic Purpura (ITP); Follow-up

MeSH Terms

Adolescent
Adult
Aged
Female
Follow-Up Studies
Humans
Laparoscopy/*methods
Male
Middle Aged
Multivariate Analysis
Purpura, Thrombocytopenic, Idiopathic/*surgery/therapy
Recurrence
Splenectomy/*methods
Time Factors
Treatment Outcome

Figure

  • Fig. 1 Early results of laparoscopic splenectony in immune thrombocytopenic purpura.

  • Fig. 2 Follow-up results of laparoscopic splenectony in immune thrombocytopenic purpura.


Reference

1. Schwarts J, Leber MD, Gillis S, Giunta A, Eldor A, Bussel JB. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol. 2003. 72:94–98.
2. Chung CW, Lee WJ, Choi JS, Ko YW, Han JS, Min YH, Kim BR. Laparoscopic splenenctomy for immune thrombocytopenic purpura-Long term result of 40 Laparoscopic splenectomies. Yonsei Med J. 1999. 40:578–587.
3. Berechtod P, McMillan R. Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood. 1989. 74:2309–2317.
4. Mazzucconi MG, Arista MC, Peraino M, Chisrolini A, Felici C, Francavilla V, Macale E, Conti L, Gandolfo GM. Long term follow-up of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy. Eur J Haematol. 1999. 62:219–222.
5. Katkhouda N, Hurwitz MB, Rivera RT, Chandra M, Wakdrep DJ, Gugenheim J, Mouiel J. Laparoscopic splenectomy outcome and efficacy in 103 consecutive patients. Ann Surg. 1998. 228:568–578.
6. Park A, Marcaccio M, Sternbach M, Witzke D, Fitzqerld P. Laparoscopic vs open splenectomy. Arch Surg. 1999. 134:1263–1269.
Article
7. Bresler L, Guerci A, Brunaud L, Ayav A, Sebbag H, Tortuyaux JM, Lederlin P, Boissel P. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura: outcome and long-term results. World J Surg. 2002. 26:111–114.
Article
8. Lee WJ, Kim BR. Laparoscopic splenectomy for chronic idiopathic thrombocytopenic purpura. Surg Laparosc Endosc. 1997. 7:209–212.
9. Kwon CH, Moon CH, Cho YP, Kim MC, Kim KH, Han JY, Lee YH, Oh SY, Kim SH, Kim JS, Kim HJ. Prognostic factors of response to laparoscopic splenectomy in patients with idiopathic thrombocytopenic purpura. J Korean Med Sci. 2005. 20:417–420.
Article
10. Difino SM, Lachant NA, Kirshner JJ, Gottlieb AJ. Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy. Am J Med. 1980. 69:430–442.
11. Szold ZA, Keidar H, Nadav L, Eldor A, Klausner JM. Chronic idiopathic thrombocytopenic purpura is a surgical disease. Surg Endsc. 2002. 16:155–158.
12. Akwari OE, Itani KM, Coleman RE, Rosse WF. Splenectomy for primary and recurrent immune thrombocytopenic purpura. Am J Hematol. 1992. 41:184–189.
13. Ddelaitre B, Blezel E, Samama G, Barrat C, Gossot D, Bresler L, Meyer C, Heyd B, Collet D, Champault G. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Surg Laparosc Endosc. 2002. 12:412–419.
14. Lynch AM, Kapila R. Overwhelmig post infection. Infec Dis Clin North Am. 1996. 10:693–707.
15. Davies JM, Barnes R, Milligan D. British Committee for Standards in Haematology Working Party of the Haematology/Oncology Task Force. Updated guideline: the prevention and treatment of infection in patients with an absent or dysfuctiona spleen. Clin Med. 2002. 2:440–443.
16. Dash S, Marwaha RK, Mohanty S. Lupus anticoagulant in ITP. Indian J Pediatr. 2004. 71:505–507.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr